logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

FDA approves mitomycin for low-grade upper tract urothelial cancer

The first approval in low-grade upper tract urothelial cancer is based on a phase 3 OLYMPUS trial.